GlassScriptPhysician profile
Lara Farouk Appiah
NPI 1689134439
$5,320.49
in general payments reported to CMS, 2019-2025
12 companies · $2,100 in 2025
The $2,100 reported for 2025 was more than what 82% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $17.79 · 2022: $95.00 · 2023: $63.12 · 2024: $3,044 · 2025: $2,100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,750 · Travel and Lodging: $1,442 · Food and Beverage: $1,015.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,750.00 |
| Travel and Lodging | $1,442.36 |
| Food and Beverage | $1,015.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,606.60 | 2024-2025 | |
| Polynovo North America LLC | $164.63 | 2025 | Novosorb Btm |
| Baxter Healthcare | $131.42 | 2025 | Perclot |
| W. L. Gore & Associates, INC. | $119.92 | 2024 | Gore Excluder Aaa Endoprosthesis |
| Integra Lifesciences Corporation | $92.28 | 2022-2024 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Davol INC. | $47.08 | 2024 | Phasix Mesh |
| Medtronic, INC. | $46.91 | 2023-2025 | Endurant Iis |
| Kci USA, INC. | $38.56 | 2022-2023 | V.A.C.Ulta, Abthera, Prevena |
| Sanara Medtech INC. | $19.94 | 2025 | Celleraterx |
| Solventum Corporation | $18.41 | 2024 | Abthera, V.A.C.Ulta, Prevena |
| Cardinal Health 200 LLC | $17.79 | 2020 | |
| Csl Behring | $16.95 | 2023 | Kcentra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lara Appiah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.